191 related articles for article (PubMed ID: 19336430)
1. Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study.
Krause K; Jaquet K; Schneider C; Haupt S; Lioznov MV; Otte KM; Kuck KH
Heart; 2009 Jul; 95(14):1145-52. PubMed ID: 19336430
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
[TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
Santoso T; Irawan C; Alwi I; Aziz A; Kosasih A; Inggriani S; Saputra A; Wintery M; Lison L
Acta Med Indones; 2011 Apr; 43(2):112-21. PubMed ID: 21785174
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
5. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study.
Beitnes JO; Hopp E; Lunde K; Solheim S; Arnesen H; Brinchmann JE; Forfang K; Aakhus S
Heart; 2009 Dec; 95(24):1983-9. PubMed ID: 19833610
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
Wollert KC; Meyer GP; Lotz J; Ringes-Lichtenberg S; Lippolt P; Breidenbach C; Fichtner S; Korte T; Hornig B; Messinger D; Arseniev L; Hertenstein B; Ganser A; Drexler H
Lancet; 2004 Jul 10-16; 364(9429):141-8. PubMed ID: 15246726
[TBL] [Abstract][Full Text] [Related]
8. Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study.
Charwat S; Lang I; Dettke M; Graf S; Nyolczas N; Hemetsberger R; Zamini S; Khorsand A; Sochor H; Maurer G; Glogar D; Gyöngyösi M
Thromb Haemost; 2010 Mar; 103(3):564-71. PubMed ID: 20076851
[TBL] [Abstract][Full Text] [Related]
9. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.
Chen SL; Fang WW; Qian J; Ye F; Liu YH; Shan SJ; Zhang JJ; Lin S; Liao LM; Zhao RC
Chin Med J (Engl); 2004 Oct; 117(10):1443-8. PubMed ID: 15498362
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
[TBL] [Abstract][Full Text] [Related]
11. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.
Yang Z; Zhang F; Ma W; Chen B; Zhou F; Xu Z; Zhang Y; Zhang D; Zhu T; Wang L; Wang H; Ding Z; Zhang Y
Cardiovasc Ther; 2010 Dec; 28(6):380-5. PubMed ID: 20337639
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
[TBL] [Abstract][Full Text] [Related]
15. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction.
Plewka M; Krzemińska-Pakuła M; Lipiec P; Peruga JZ; Jezewski T; Kidawa M; Wierzbowska-Drabik K; Korycka A; Robak T; Kasprzak JD
Am J Cardiol; 2009 Nov; 104(10):1336-42. PubMed ID: 19892047
[TBL] [Abstract][Full Text] [Related]
16. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study.
Penn MS; Ellis S; Gandhi S; Greenbaum A; Hodes Z; Mendelsohn FO; Strasser D; Ting AE; Sherman W
Circ Res; 2012 Jan; 110(2):304-11. PubMed ID: 22052917
[TBL] [Abstract][Full Text] [Related]
17. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
[TBL] [Abstract][Full Text] [Related]
18. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
[TBL] [Abstract][Full Text] [Related]
19. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.
Kang HJ; Kim HS; Zhang SY; Park KW; Cho HJ; Koo BK; Kim YJ; Soo Lee D; Sohn DW; Han KS; Oh BH; Lee MM; Park YB
Lancet; 2004 Mar; 363(9411):751-6. PubMed ID: 15016484
[TBL] [Abstract][Full Text] [Related]
20. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
